… progress of protein nanocages in enzyme self-immobilization is reviewed, and the possible
research directions in the future … of self-assembled carbonic anhydrase supraparticles for CO …

… and International Pharmaceutical Abstracts (IPA) analysis. A … are typically reached only in
advanced stages of the disease … presence of antibodies against Carbonic Anhydrase II (anti-…

… , and muscle atrophy are still barriers to significant progress. … past and current studies, and
future directions in PEG fusion. … commercial antibodies against Carbonic Anhydrase II (CA2) …

… progress … drugs acting on new targets (epigenetic interferers, synaptic vesicle glycoprotein
2A modulators, mammalian target of rapamycin signal pathway blockers, carbonic anhydrase …

… Carbonic anhydrase inhibition ameliorates inflammation and experimental pulmonary … In
this review, we described the advances in HAPE mechanisms and in the clinical translation of …

… Design and synthesis of novel nonsteroidal anti-inflammatory drugs and carbonic anhydrase
inhibitors hybrids(NSAIDs-CAIs) for the treatment of rheumatoid arthritis [J]. J Med Chem, …

… , and topological analysis and clustering analysis were … 2 (MMP2) and predicted targets
of carbonic anhydrase 1 (CA1), … Progress on prevention and treatment of Chinese medicine …

… of drug development and combat the rising threat of multi-drug resistance. The establishment
of modern molecular biology, along with the developments of … Plant carbonic anhydraselike …

… This paper summarizes the current research progress of SGLT2 … for future structure⁃based
drug optimisation of inhibitors. … by baseline KDIGO risk categories: a post hoc analysis of the …

… Research progress on the effect of sclerostin monoclonal antibody in treating osteoporosis
… Sclerostin monoclonal antibody: A future new drug for the treatment of osteoporosis. Chin J …